EUVIMEDEUVIMED entdecken
Crossref

Caffeine and Cognitive Performance in Healthy Adults: Domain-Specific Effects and Dosing Considerations

Paulina Troncoso-Escudero, Marion Erica Feddersen Welkner, Jae Kyung Jo, Daniela Vicinansa Monaco Ferreira, Karla Andrade Ruiz, Fernando Jose Gomez Juarez, Natália Puschnick Gimenez, Jorgelina Stegmann, Henrique Balseiro Zin, Alice Campanholo de Oliveira, Yulissa Hernández Frías, Lissa Raquel Sandoval Castillo und 15 weitere

Principles and Practice of Clinical Research Journal · 26.04.2026 · 11 (4)

DOI: 10.21801/ppcrj.2025.114.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Principles and Practice of Clinical Research Journal, online erschienen am 26.04.2026. Verfasst von Paulina Troncoso-Escudero und 26 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Caffeine is widely consumed for its potential cognitive-enhancing effects, yet findings across cognitive domains and dosing regimens remain heterogeneous.

Objectives

This systematic review aimed to evaluate the effects of low (100-200 mg) and high (300-400 mg) doses of caffeine on cognitive performance, specifically attention, memory, and executive function in healthy adults aged 18-60 years, compared to placebo.

Methods

We included randomized controlled trials (RCTs) that evaluated the effects of low-dose (100-200 mg) or high-dose (300-400 mg) caffeine on cognitive performance in healthy adults (aged 18-60 years). These studies assessed cognitive domains such as attention, memory, or executive function using standardized cognitive tests. Studies were excluded if they involved pediatric (60 years), individuals with cognitive impairments, or if they assessed non-cognitive outcomes. Databases searched included PubMed, Embase, Scopus, and Web of Science, from 2015 until 2025. Risk of bias in the included studies was assessed using Cochrane Risk-of-Bias (RoB2-tool). Data extraction and analysis were performed using Covidence.

Results

Twenty RCTs (n = 951; ages 18–60) were included. Low-to-moderate caffeine doses (100–200 mg) consistently improved sustained attention, vigilance, and reaction time, with stronger effects observed in low habitual consumers. Working memory showed overall improvement, though findings varied by task and baseline caffeine intake. Executive function outcomes were heterogeneous, with task-specific benefits but no consistent pattern. Mood and arousal frequently improved, while higher doses (≥300 mg) produced null or inconsistent effects. Importantly, although studies evaluated varying caffeine doses, none directly compared low versus high doses within the same experimental design, precluding firm conclusions regarding dose–response superiority. Risk of bias was mostly moderate, reflecting issues with blinding and outcome reporting.

Conclusions

Caffeine appears to exert domain-specific cognitive effects in healthy adults, with more consistent benefits observed in attention-related measures than in executive function. The absence of direct low–high dose comparisons limits conclusions regarding optimal dosing; though trials with low dose seem to produce larger effects. Future trials should directly compare dosing strategies and comprehensively assess multiple cognitive domains to clarify potential tradeoffs between attentional enhancement and executive performance.

Zitieren

APA

Troncoso-Escudero, P., Welkner, M. E. F., Jo, J. K., Ferreira, D. V. M., Ruiz, K. A., Juarez, F. J. G., Gimenez, N. P., Stegmann, J., Zin, H. B., Oliveira, A. C. D., Frías, Y. H., Castillo, L. R. S., Kemahli, M. N. C., Barroso, P. S., Paez, D. P., Santos, L. C. D., Bennewart, H., Resende, L. A. D. L., Shahulhameed, S. P., …, & Rosado, R. (2026). Caffeine and Cognitive Performance in Healthy Adults: Domain-Specific Effects and Dosing Considerations. Principles and Practice of Clinical Research Journal, 11(4). https://doi.org/10.21801/ppcrj.2025.114.7

Vancouver

Troncoso-Escudero P, Welkner MEF, Jo JK, Ferreira DVM, Ruiz KA, Juarez FJG, et al. Caffeine and Cognitive Performance in Healthy Adults: Domain-Specific Effects and Dosing Considerations. Principles and Practice of Clinical Research Journal. 2026;11(4). doi:10.21801/ppcrj.2025.114.7

BibTeX
@article{TroncosoEscudero2026,
  author = {Troncoso-Escudero, Paulina and Welkner, Marion Erica Feddersen and Jo, Jae Kyung and Ferreira, Daniela Vicinansa Monaco and Ruiz, Karla Andrade and Juarez, Fernando Jose Gomez and Gimenez, Natália Puschnick and Stegmann, Jorgelina and Zin, Henrique Balseiro and Oliveira, Alice Campanholo de and Frías, Yulissa Hernández and Castillo, Lissa Raquel Sandoval and Kemahli, Miray Nilufer Cimsit and Barroso, Priscila Sales and Paez, Diego Perez and Santos, Letícia Cabreira dos and Bennewart, Hanna and Resende, Laura Amaral de Lara and Shahulhameed, Siddiha Poovelil and Espinoza, Fernando and Aranguren, Paula and Bertagnoli, Paula and Burgos, Sarah and Hassan, Ala and Paschos, Nikolaos and Roa, Carlos and Rosado, Roy},
  title = {Caffeine and Cognitive Performance in Healthy Adults: Domain-Specific Effects and Dosing Considerations},
  journal = {Principles and Practice of Clinical Research Journal},
  year = {2026},
  volume = {11},
  number = {4},
  doi = {10.21801/ppcrj.2025.114.7}
}
Kostenlos starten →